Analyst Consensus ?
ConsensusBuy64 ratings
Bullish5484.4%
Neutral69.4%
Bearish46.2%
Slb N.V. · SLB · FY2024 Q2 · Calendar Q3 2024
SLB posts strong Q2 while maintaining full-year guidance
SLB's Q2 results support a constructive operating narrative: international demand, subsea activity, and digital adoption drove growth while management maintained its full-year outlook. The key test is whether those drivers can offset weaker U.S. land activity and integration and execution risks.
Reported Before market openNYSEEnergy
$72.86B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.85
Consensus $0.83
EPS surprise
+2.4%
Reported versus consensus
Reported revenue
$9.15B
Consensus $9.08B
Revenue surprise
+0.8%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+1.9%
Event window
SPY move
-0.7%
Same window
Abnormal move
+2.6%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
-9.8%
Up to 20 sessions
SLBSPY benchmark
Ask FN2 about SLB FY2024 Q2
Transcript, numbers and history already loaded
Why did SLB rise 1.9% after beating EPS estimates in FY2024 Q2?What changed in SLB's guidance and outlook in FY2024 Q2?Give me the bull and bear case for SLB after FY2024 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the company delivered another strong period with international growth, higher Digital & Integration margins, and a more developed ChampionX integration agenda. Management maintained, rather than raised, full-year guidance; execution, offshore backlog conversion, and digital-margin durability remain the main watchpoints.
Guidance delta
Maintained: management reaffirmed full-year EBITDA growth guidance of 14–15% and a margin of at least 25%.
Key takeaways
- Q2 revenue was $9.1 billion, up 5% sequentially, and adjusted EBITDA was $1.0 billion, up 11%.
- International markets, led by the Middle East and Asia, were the primary growth engine.
- Digital & Integration revenue increased 10% sequentially and its margin expanded to 31%.
- ChampionX integration, carbon capture, and OneSubsea remain central to the operating narrative.
- Management reported $776 million of free cash flow and $1.5 billion returned to shareholders in the first half.
Management priorities
- Integrate ChampionX and evaluate portfolio segmentation to better highlight digital.
- Scale carbon-capture offerings and pursue DOE-funded projects in North America.
- Deploy all-electric subsea technology in Brazil and other basins.
- Continue ERP implementation and functional-efficiency efforts.
- Modernize customers’ digital infrastructure worldwide.
Follow SLB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$49.09Current
$42Low
$57.51Average
$81High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Oct 19, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 19, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 15, 2026 |
| UBS | Buy | Buy | Maintain | Sep 14, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 27, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 27, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 27, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 27, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 10, 2026 |
| Stifel | Buy | Buy | Maintain | Jun 18, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jun 16, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 11, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 27, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 4, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 2, 2026 |
| Freedom Broker | Sell | Hold | Downgrade | Jan 27, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jan 26, 2026 |
| Freedom Capital Markets | Hold | Buy | Downgrade | Jan 6, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 5, 2025 |
| Benchmark | Buy | Buy | Maintain | Jul 22, 2024 |
| HSBC | Buy | Buy | Maintain | Apr 4, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jan 12, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 25, 2022 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 26, 2022 |
| Oddo Securities | Outperform | Outperform | Maintain | Oct 14, 2021 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 26, 2021 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 19, 2020 |
| Northland Capital Markets | Outperform | Outperform | Maintain | May 29, 2020 |
| CFRA | Sell | Hold | Downgrade | Mar 9, 2020 |
| Tudor Pickering | Buy | Sell | Upgrade | Nov 20, 2019 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 20, 2019 |
| Gabelli & Co. | Buy | Buy | Maintain | Jun 27, 2019 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Jun 7, 2019 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Apr 3, 2018 |
| Bank of America | Buy | Neutral | Upgrade | Feb 26, 2018 |
| Griffin Securities | Buy | Neutral | Upgrade | Feb 12, 2018 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Jan 22, 2018 |
| Loop Capital | Buy | Buy | Maintain | Oct 26, 2017 |
| Guggenheim | Neutral | Buy | Downgrade | Jun 27, 2017 |
| Nomura | Buy | Buy | Maintain | Aug 16, 2016 |
| Societe Generale | Buy | Hold | Upgrade | Jul 19, 2016 |
| Scotia Howard Weil | Sector Outperform | Sector Outperform | Maintain | May 12, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Apr 20, 2016 |
| DA Davidson | Buy | Buy | Maintain | Feb 19, 2016 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 7, 2016 |
| GMP Securities | Buy | Buy | Maintain | Jan 5, 2016 |
| William Blair | Outperform | Market Perform | Upgrade | Dec 18, 2015 |
| KLR Group | Buy | Buy | Maintain | Dec 14, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Sep 21, 2015 |
| Macquarie | Neutral | Neutral | Maintain | Sep 9, 2015 |
| Seaport Global | Buy | Neutral | Upgrade | Jul 20, 2015 |
| CLSA | Underperform | Buy | Downgrade | Apr 20, 2015 |
| Baird | Outperform | Outperform | Maintain | Apr 19, 2015 |
| RS Platou Markets | Sell | Neutral | Downgrade | Jan 20, 2015 |
| ISI Group | Buy | Buy | Maintain | Oct 16, 2014 |
| IBERIA Capital Partners | Outperform | Sector Perform | Upgrade | Sep 25, 2014 |
| Drexel Hamilton | Buy | Buy | Maintain | Jun 20, 2014 |
| Argus Research | Buy | Buy | Maintain | Apr 29, 2014 |
| Johnson Rice | Overweight | Equal Weight | Upgrade | Jan 21, 2014 |
| Global Hunter Securities | Buy | Neutral | Upgrade | Jul 22, 2013 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 3, 2012 |
| Dahlman Rose | Buy | Buy | Maintain | Mar 30, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $49.09. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $63 | $49.5 | +28.3% | Oct 19, 2026 |
| UBS | Josh Silverstein | $75 | $56.06 | +52.8% | Sep 14, 2026 |
| UBS | Josh Silverstein | $72 | $58.74 | +46.7% | Sep 9, 2026 |
| Evercore ISI | Analyst unavailable | $66 | $52.42 | +34.4% | Jul 27, 2026 |
| Susquehanna | Charles Minervino | $62 | $52.42 | +26.3% | Jul 27, 2026 |
| Piper Sandler | Analyst unavailable | $64 | $52.42 | +30.4% | Jul 27, 2026 |
| Barclays | David Anderson | $67 | $52.42 | +36.5% | Jul 27, 2026 |
| Jefferies | Analyst unavailable | $66 | $52.42 | +34.4% | Jul 26, 2026 |
| Barclays | Analyst unavailable | $64 | $47.55 | +30.4% | Jul 16, 2026 |
| Morgan Stanley | Joe Laetsch | $54 | $47.83 | +10.0% | Jul 15, 2026 |
| Raymond James | Analyst unavailable | $61 | $47.94 | +24.3% | Jul 10, 2026 |
| Wolfe Research | Carlos Escalante | $62 | $47.1 | +26.3% | Jul 8, 2026 |
| Susquehanna | Charles Minervino | $55 | $47.19 | +12.0% | Jul 8, 2026 |
| UBS | Analyst unavailable | $66 | $45.54 | +34.4% | Jul 1, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $64 | $50.33 | +30.4% | Jun 18, 2026 |
| Bernstein | Analyst unavailable | $71 | $53.27 | +44.6% | May 11, 2026 |
| Barclays | Analyst unavailable | $66 | $55.16 | +34.4% | May 7, 2026 |
| Susquehanna | Charles Minervino | $65 | $55.58 | +32.4% | Apr 27, 2026 |
| BMO Capital | Phillip Jungwirth | $63 | $55.56 | +28.3% | Apr 27, 2026 |
| Morgan Stanley | Analyst unavailable | $57 | $55.84 | +16.1% | Apr 27, 2026 |
| Evercore ISI | Analyst unavailable | $64 | $56.15 | +30.4% | Apr 27, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $61 | $56.15 | +24.3% | Apr 27, 2026 |
| Barclays | Analyst unavailable | $51 | $56.15 | +3.9% | Apr 27, 2026 |
| Jefferies | Analyst unavailable | $65 | $56.15 | +32.4% | Apr 26, 2026 |
| Morgan Stanley | Joe Laetsch | $55 | $51.49 | +12.0% | Apr 15, 2026 |
| Piper Sandler | Analyst unavailable | $59 | $51.49 | +20.2% | Apr 15, 2026 |
| Jefferies | Analyst unavailable | $58 | $48.38 | +18.2% | Feb 1, 2026 |
| Loop Capital Markets | Sergey Pigarev | $48 | $50.31 | -2.2% | Jan 27, 2026 |
| UBS | Josh Silverstein | $61 | $50.46 | +24.3% | Jan 27, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $56 | $49.32 | +14.1% | Jan 26, 2026 |
| Susquehanna | Analyst unavailable | $58 | $49.66 | +18.2% | Jan 26, 2026 |
| RBC Capital | Keith Mackey | $54 | $49.58 | +10.0% | Jan 26, 2026 |
| UBS | Analyst unavailable | $54 | $49.88 | +10.0% | Jan 26, 2026 |
| BMO Capital | Analyst unavailable | $55 | $49.15 | +12.0% | Jan 26, 2026 |
| Barclays | Analyst unavailable | $49 | $49.15 | -0.2% | Jan 26, 2026 |
| Morgan Stanley | Analyst unavailable | $50 | $47.76 | +1.9% | Jan 21, 2026 |
| RBC Capital | Keith Mackey | $51 | $46.78 | +3.9% | Jan 15, 2026 |
| Goldman Sachs | Neil Mehta | $49 | $45.9 | -0.2% | Jan 14, 2026 |
| Susquehanna | Analyst unavailable | $52 | $42.89 | +5.9% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $54 | $43.8 | +10.0% | Jan 6, 2026 |
| Piper Sandler | Analyst unavailable | $45 | $38.53 | -8.3% | Dec 18, 2025 |
| Barclays | David Anderson | $47 | $37.61 | -4.3% | Dec 17, 2025 |
| UBS | Analyst unavailable | $50 | $39.48 | +1.9% | Dec 12, 2025 |
| Cowen & Co. | Analyst unavailable | $57 | $40.67 | +16.1% | Dec 11, 2025 |
| Bernstein | Guillaume Delaby | $52.3 | $39.94 | +6.5% | Dec 11, 2025 |
| Redburn Partners | Sebastian Erskine | $48 | $36.06 | -2.2% | Nov 3, 2025 |
| UBS | Josh Silverstein | $44 | $33.64 | -10.4% | Oct 21, 2025 |
| Piper Sandler | Analyst unavailable | $42 | $32.63 | -14.4% | Oct 20, 2025 |
| Piper Sandler | Analyst unavailable | $41 | $32.57 | -16.5% | Oct 16, 2025 |
| Bernstein | Guillaume Delaby | $47.6 | $34.12 | -3.0% | Oct 8, 2025 |
| Jefferies | Lloyd Byrne | $51 | $35.47 | +3.9% | Jul 27, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $52 | $34.5 | +5.9% | Jul 16, 2025 |
| UBS | Analyst unavailable | $45 | $35.91 | -8.3% | Jul 2, 2025 |
| Jefferies | Analyst unavailable | $53 | $33.18 | +8.0% | Jun 26, 2025 |
| Raymond James | Analyst unavailable | $43 | $34.1 | -12.4% | Apr 28, 2025 |
| Susquehanna | Charles Minervino | $48 | $33.92 | -2.2% | Apr 14, 2025 |
| Jefferies | Lloyd Byrne | $59 | $42.1 | +20.2% | Mar 27, 2025 |
| Barclays | David Anderson | $61 | $42.43 | +24.3% | Oct 21, 2024 |
| Susquehanna | Bascome Majors | $56 | $42.54 | +14.1% | Oct 21, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $60 | $42.51 | +22.2% | Oct 21, 2024 |
| Citigroup | Scott Gruber | $54 | $42.5 | +10.0% | Oct 21, 2024 |
| Raymond James | James Rollyson | $57 | $41.92 | +16.1% | Oct 21, 2024 |
| Goldman Sachs | Neil Mehta | $52 | $41.92 | +5.9% | Oct 21, 2024 |
| Jefferies | Lloyd Byrne | $68 | $43.94 | +38.5% | Oct 2, 2024 |
| CFRA | Stewart Glickman | $42 | $39.36 | -14.4% | Sep 10, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $65 | $49.68 | +32.4% | Jul 22, 2024 |
| Evercore ISI | James West | $74 | $49.38 | +50.7% | Jul 22, 2024 |
| RBC Capital | Mark Miller | $80 | $23.37 | +63.0% | Jul 15, 2024 |
| RBC Capital | Keith Mackey | $69 | $54.68 | +40.6% | Apr 3, 2024 |
| Societe Generale | Guillaume Delaby | $81 | $52.58 | +65.0% | Dec 22, 2023 |
| Susquehanna | Charles Minervino | $59 | $52.15 | +20.2% | Oct 24, 2022 |
| Bank of America Securities | Chase Mulvehill | $55 | $52.15 | +12.0% | Oct 24, 2022 |
| Wolfe Research | Sam Margolin | $51 | $50.41 | +3.9% | Oct 21, 2022 |
| Evercore ISI | James West | $60 | $50.41 | +22.2% | Oct 21, 2022 |
| Barclays | David Anderson | $59 | $36.64 | +20.2% | Jun 20, 2022 |
| Evercore ISI | James West | $51 | $39.92 | +3.9% | Apr 29, 2022 |
| Barclays | David Anderson | $55 | $39.01 | +12.0% | Apr 29, 2022 |
| HSBC | Abhishek Kumar | $44.2 | $39.95 | -10.0% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $55 | $41.65 | +12.0% | Apr 25, 2022 |
| Piper Sandler | Ian Macpherson | $55 | $43.25 | +12.0% | Apr 14, 2022 |
| Stifel Nicolaus | Stephen Gengaro | $50 | $41.33 | +1.9% | Apr 11, 2022 |
| Goldman Sachs | Neil Mehta | $51 | $42.21 | +3.9% | Mar 30, 2022 |
| Susquehanna | Bascome Majors | $54 | $43.4 | +10.0% | Mar 10, 2022 |
| BNP Paribas | Nick Konstantakis | $45 | $39.8 | -8.3% | Jan 26, 2022 |
| Bank of America Securities | Chase Mulvehill | $44 | $36.49 | -10.4% | Jan 24, 2022 |
| Stephens | Tommy Moll | $45 | $36.49 | -8.3% | Jan 24, 2022 |
| Morgan Stanley | Connor Lynagh | $43 | $36.49 | -12.4% | Jan 24, 2022 |
| J.P. Morgan | Arun Jayaram | $43 | $36.49 | -12.4% | Jan 24, 2022 |
| BMO Capital | Phillip Jungwirth | $43 | $36.49 | -12.4% | Jan 24, 2022 |
| Barclays | David Anderson | $48 | $34.11 | -2.2% | Oct 25, 2021 |
| Oddo BHF | Baptiste Lebacq | $44.5 | $33.28 | -9.4% | Oct 14, 2021 |
| HSBC | Abhishek Kumar | $25 | $27.31 | -49.1% | Aug 4, 2021 |
| Piper Sandler | Ian Macpherson | $31 | $29.12 | -36.9% | Jul 26, 2021 |
Track every rating change on SLB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSLB N.V. engages in the provision of technology for the energy industry worldwide. The company operates through four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems. The company provides field development and hydrocarbon production, carbon management, and integration of adjacent energy systems; reservoir interpretation and data processing services for exploration data; and well construction and production improvement services and products. It also offers subsurface geology and fluids evaluation information; stimulation services to restore or enhance well productivity through hydraulic fracturing, matrix stimulation, and water treatment; and intervention services to oil and gas operators.…
Historical context
All SLB earningsLatest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the SLB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
- Polygon adjusted daily market bars · 2026-10-20T04:20:42.415870+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-20T04:20:42.413099+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-20. For educational purposes only; not investment advice.